Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion type Assertion NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_head.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion description "[Preclinical evaluation of the mitogen-activated protein kinase kinase 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) showed significant differential sensitivity in Ras pathway-mutated ALL compared with WT cells both in vitro and in an orthotopic xenograft model engrafted with primary ALL; in the latter, reduced RAS-mutated CNS leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_provenance.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion evidence source_evidence_literature NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_provenance.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion SIO_000772 25253770 NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_provenance.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion wasDerivedFrom befree-20150227 NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_provenance.
- NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_assertion wasGeneratedBy ECO_0000203 NP645974.RAaeZ8QBZjYeSWuB8wrr0oMZOPGpF6J9fi8xWlBuBqVKs130_provenance.